Supercomputing Grids Close Ranks to Meet Medical Challenge

Two supercomputing networks have successfully joined forces in a distributed simulation of the effectiveness of drugs on mutant strains of the Human Immunodeficiency Virus (HIV). Although the Distributed European Infrastructure for Supercomputing Application (DEISA) and the GridAustralia-Australian Partnership for Advanced Computing (APAC) infrastructures use incompatible underlying platforms (UNICORE 5 and Globus Tool Kit, respectively), the researchers were able to spread the computing tasks over the two high performance computing (HPC) grids.

As HIV is highly mutable, it frequently becomes resistant to drugs that reduce patients' viral loads and bind and inhibit critical viral enzymes. As a result, patients will then have to change their drug regime. It is essential to select the right drug in order to provide the best possible treatment, as well as to prevent the development of further drug resistance.

The simulations run by DEISA and APAC are intended to help this process by testing the effectiveness of particular antiviral drugs against a number of mutant HIV strains. They analyse average interaction energies between anti-HIV drugs and the HIV protease strain, hoping to thus provide an accurate assessment of the drugs' effectiveness.

A huge number of calculations is needed for this, and this is why the process necessitates the processing power of supercomputers. Researchers were sure that time-to-solution would be further reduced by employing several supercomputers in a grid and spreading the tasks over different grids at the same time.

This is the first time that a reliable, automated bidirectional data transfer between the European DEISA grid and the Australian APAC grid has been demonstrated.

For further information, please visit:
http://www.deisa.org

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...